PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China · Delayed Price · Currency is CNY 54.38
+4.87 (9.84%)
Aug 20, 2026, 3:04 PM CST
SHE:300725 Revenue
PharmaBlock Sciences (Nanjing) had revenue of 551.43M CNY in the quarter ending June 30, 2026, with 18.66% growth. This brings the company's revenue in the last twelve months to 2.11B, up 13.45% year-over-year. In the year 2025, PharmaBlock Sciences (Nanjing) had annual revenue of 1.97B with 16.93% growth.
Revenue (ttm)
2.11B
Revenue Growth
+13.45%
P/S Ratio
5.99
Revenue / Employee
815.35K
Employees
2,593
Market Cap
12.67B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.97B | 285.86M | 16.93% |
| Dec 31, 2024 | 1.69B | -36.58M | -2.12% |
| Dec 31, 2023 | 1.73B | 130.50M | 8.18% |
| Jan 1, 2023 | 1.59B | 393.07M | 32.71% |
| Dec 31, 2021 | 1.20B | 179.40M | 17.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.